4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-23-058488
Options or other derivatives
- Director acquired 7,936,759 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2023-12-13 | Grant or award · Warrants to purchase Common Stock | +593,452 | $3.15 | $1,869,314 | 1,563,672 | I |
| BAKER BROS. ADVISORS LP Director | 2023-12-13 | Grant or award · Warrants to purchase Common Stock | +7,343,307 | $3.15 | $23,130,683 | 17,968,343 | I |
Loading xslF345X05/doc4.xml…